Full text Pdf 

http://doi.org/10.31288/oftalmolzh201224244

THE ULTRASTRUCTURAL CHANGES IN THE MALIGNANT EPITHELIAL EYELID TUMORS (MEET) AFTER RADIOTHERAPY AND COMBINED TREATMENT (RADIOTHERAPY+CRYODESTRUCTION)

Safronenkova I. A., Dumbrova N. E., Molchanuk N. I.

The ultrastructural changesin MEET at the radiotherapyand combined treatment (radiotherapy+cryodestruction) of 8 patients have been studied. It was established the various damages in tumoral tissue after radiotherapy. Some cases showed the deep damages of ultrastructure and disintegration of tumoral cells. In another cases cells were changed slightly and kept the tumoral signs. After combined treatment in all cases there were observed the destruc¬tion and disintegration of tumoral tissue structures with various degree. The ultrastructural changes in tumoral tissue after radiotherapy and clinical data comparison confirms the fact that the more tumor is sensitive to radial influence, the more it decreases and the more destructive changes are expressed in it.

References

1.Зінченко В. А. Набута радіорезистентність пухлинних клітин. / Зінченко В. А., Чащина Л. І. // УРЖ. — 2006. — № 3. — С.272- 276.

2.Лобко Г. И. Резистентность опухолей: генетические аспекты. / Лобко Г Н., Порубова Г М. // Минск: На¬ука и техника. — 1989. — 143 с.

3.Иммуногистохимическое изучение предсказательного значения онкобелков р53, НЕЫ-2, с-тус при лу¬чевой терапии плоскоклеточного рака шейки матки I Н. А. Гаспарян, К. М. Пожарисский, Г. М. Жаринов [и др.] || Вопросы онкологии. — 2007. — Т.53. № 4. — С. 439- 444.

4.Alsner J. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck | J. Alsner, S. B. Sorensen, J. Over-gaard || Radiat Oncol. — 2001. — V.59. — P.179- 185.
Crossref

5.Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer | O. U. Ataman, S. M. Bentzen, G. D. Wilson [et al] || Eur. J. Cancer. — 2004. — V.40. — P.2734-2741.
Crossref

6.Prognostic factor in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53. | F Ong, M. F Moonen Luc, M. P. W. Gallee [et al] || Radiat. Oncol. — 2001. — V.61. — P.169 - 175.
Crossref